NCT00263575 2024-06-18
Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients
Kyowa Kirin Co., Ltd.
Phase 3 Completed
Clinical Trials
5 trialsNCT05037539 2022-08-31
Efficacy of Injectable Fentanyl in Sublingual Route Versus Oral Morphine Syrup for Breakthrough Pain
Department of Medical Services Ministry of Public Health of Thailand
Phase 1/2 Completed
NCT03809455 2020-04-22
FARADI
UNICANCER
Phase 2 Withdrawn
NCT02869321 2019-05-13
ANTALGIP
Central Hospital, Nancy, France
Phase 4 Completed
NCT00236041 2014-05-09
Efficacy/Safety Study of ACTIQ® for Opioid-Tolerant Children and Adolescents With Breakthrough Pain (BTP)
Teva Branded Pharmaceutical Products R&D, Inc.
Phase 2 Completed